0001209191-23-026065.txt : 20230428
0001209191-23-026065.hdr.sgml : 20230428
20230428165312
ACCESSION NUMBER: 0001209191-23-026065
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230426
FILED AS OF DATE: 20230428
DATE AS OF CHANGE: 20230428
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lucas Svetlana
CENTRAL INDEX KEY: 0001781292
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 23867703
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10240 SORRENTO VALLEY ROAD
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8587318389
MAIL ADDRESS:
STREET 1: 10240 SORRENTO VALLEY ROAD
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-26
0
0001339970
aTYR PHARMA INC
LIFE
0001781292
Lucas Svetlana
C/O ATYR PHARMA, INC.
10240 SORRENTO VALLEY ROAD, SUITE 300
SAN DIEGO
CA
92121
1
0
0
0
0
Common stock
2023-04-26
4
M
0
6000
A
6000
D
Restricted Stock Unit
2023-04-26
4
M
0
6000
0.00
D
Common Stock
6000
0
D
Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022.
RSUs convert into common stock on a one-for-one basis.
The RSUs fully vested one year from the grant date which was April 26, 2022.
/s/ Nancy E. Denyes, attorney-in-fact
2023-04-28